'Remarkable' Alzheimer's drug reduces cognitive decline, study shows
US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing serious side effects.In an analysis of nearly 1,200 people in the early...
www.rawstory.com